Gene · 51185
Papers2,935
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,441 to 1,460 of 2,935
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Phenyl-Glutarimides: Alternative Cereblon Binders for the Design of PROTACs. | Angew Chem Int Ed Engl | 2021 | 34614283 | PubTator, text mining | PubMed |
| Partial Trisomy 13q/Monosomy 3p Resulting from a Paternal Reciprocal 3p;13q Translocation in a Boy with Facial Dysmorphism and Hypertrophic Cardiomyopathy. | Mol Syndromol | 2021 | 34602958 | PubTator, text mining | PubMed |
| Chemoselective Electrosynthesis Using Rapid Alternating Polarity. | J Am Chem Soc | 2021 | 34596395 | PubTator, text mining | PubMed |
| The CRL4DCAF1 cullin-RING ubiquitin ligase is activated following a switch in oligomerization state. | EMBO J | 2021 | 34595758 | PubTator, text mining | PubMed |
| Caspase-8 Regulates the Antimyeloma Activity of Bortezomib and Lenalidomide. | J Pharmacol Exp Ther | 2021 | 34588172 | PubTator, text mining | PubMed |
| A selective WDR5 degrader inhibits acute myeloid leukemia in patient-derived mouse models. | Sci Transl Med | 2021 | 34586829 | PubTator, text mining | PubMed |
| USP15 antagonizes CRL4CRBN-mediated ubiquitylation of glutamine synthetase and neosubstrates. | Proc Natl Acad Sci U S A | 2021 | 34583995 | PubTator, text mining | PubMed |
| Structural Characterization of Degrader-Induced Ternary Complexes Using Hydrogen-Deuterium Exchange Mass Spectrometry and Computational Modeling: Implications for Structure-Based Design. | ACS Chem Biol | 2021 | 34582690 | PubTator, text mining | PubMed |
Autozygosity mapping in consanguineous Pakistani families identifies nine non-overlapping novel linkage intervals for autosomal recessive non-syndromic mental retardation (AR-NSMR); shows genetic heterogeneity for AR-NSMR. | J Pak Med Assoc | 2021 | 34580524 | PubTator, text mining | PubMed |
| Clonal Evolution of Multiple Myeloma-Clinical and Diagnostic Implications. | Diagnostics (Basel) | 2021 | 34573876 | PubTator, text mining | PubMed |
| Targeting the CDK6 Dependence of Ph+ Acute Lymphoblastic Leukemia. | Genes (Basel) | 2021 | 34573335 | PubTator, text mining | PubMed |
| The PD-1/PD-L1 Checkpoint in Normal Germinal Centers and Diffuse Large B-Cell Lymphomas. | Cancers (Basel) | 2021 | 34572910 | PubTator, text mining | PubMed |
| Rapid Progress in the Use of Immunomodulatory Drugs and Cereblon E3 Ligase Modulators in the Treatment of Multiple Myeloma. | Cancers (Basel) | 2021 | 34572892 | PubTator, text mining | PubMed |
| Harnessing the Immune System to Fight Multiple Myeloma. | Cancers (Basel) | 2021 | 34572773 | PubTator, text mining | PubMed |
| Vincristine in Combination Therapy of Cancer: Emerging Trends in Clinics. | Biology (Basel) | 2021 | 34571726 | PubTator, text mining | PubMed |
| Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders. | Nat Cancer | 2021 | 34568836 | PubTator, text mining | PubMed |
| Identification of Potential Prognostic Biomarker for Predicting Survival in Multiple Myeloma Using Bioinformatics Analysis and Experiments. | Front Genet | 2021 | 34567073 | PubTator, text mining | PubMed |
| An Integrative Co-localization (INCO) Analysis for SNV and CNV Genomic Features With an Application to Taiwan Biobank Data. | Front Genet | 2021 | 34567069 | PubTator, text mining | PubMed |
| Neurodevelopmental Disorders (NDD) Caused by Genomic Alterations of the Ubiquitin-Proteasome System (UPS): the Possible Contribution of Immune Dysregulation to Disease Pathogenesis. | Front Mol Neurosci | 2021 | 34566579 | PubTator, text mining | PubMed |
Lenalidomide in combination with R-CHOP produces high response rates and progression-free survival in new, untreated diffuse large B-cell lymphoma transformed from follicular lymphoma: results from the Phase 2 MC078E study. | Blood Cancer J | 2021 | 34564694 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/51185/papers?page=73